Kewaunee Scientific (NASDAQ:KEQU) CEO Thomas David Hull III Sells 2,177 Shares

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 2,177 shares of the company’s stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $37.50, for a total value of $81,637.50. Following the completion of the sale, the chief executive officer owned 33,000 shares of the company’s stock, valued at $1,237,500. This represents a 6.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, December 31st, Thomas David Hull III sold 629 shares of Kewaunee Scientific stock. The shares were sold at an average price of $37.66, for a total transaction of $23,688.14.
• On Tuesday, December 30th, Thomas David Hull III sold 29 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.00, for a total value of $1,102.00.
• On Monday, December 29th, Thomas David Hull III sold 884 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.01, for a total transaction of $33,600.84.
• On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total transaction of $39,000.00.

Kewaunee Scientific Stock Up 0.0%

Kewaunee Scientific stock traded up $0.01 during midday trading on Thursday, reaching $37.26. The stock had a trading volume of 909 shares, compared to its average volume of 6,888. Kewaunee Scientific Corporation has a 1-year low of $30.33 and a 1-year high of $71.33. The firm’s fifty day simple moving average is $39.10 and its 200-day simple moving average is $46.95. The stock has a market capitalization of $106.94 million, a P/E ratio of 9.46 and a beta of 0.55. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.71 and a current ratio of 2.48.

Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Wednesday, December 10th. The technology company reported $0.91 earnings per share for the quarter. The business had revenue of $70.10 million during the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. During the same period last year, the business posted $1.01 EPS.

Wall Street Analysts Forecast Growth

KEQU has been the topic of several recent research reports. Wall Street Zen cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, December 13th. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Kewaunee Scientific currently has an average rating of “Hold”.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. First Trust Advisors LP boosted its stake in shares of Kewaunee Scientific by 3.4% in the 2nd quarter. First Trust Advisors LP now owns 6,726 shares of the technology company’s stock worth $395,000 after buying an additional 222 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Kewaunee Scientific by 0.9% during the second quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock valued at $1,410,000 after purchasing an additional 223 shares during the last quarter. US Bancorp DE grew its stake in Kewaunee Scientific by 80.0% in the 3rd quarter. US Bancorp DE now owns 900 shares of the technology company’s stock valued at $38,000 after buying an additional 400 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares during the period. Finally, Ritholtz Wealth Management boosted its position in shares of Kewaunee Scientific by 6.1% in the third quarter. Ritholtz Wealth Management now owns 13,734 shares of the technology company’s stock valued at $586,000 after acquiring an additional 785 shares during the period. 32.69% of the stock is owned by institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.